Xinyong Liu

617 total citations
31 papers, 489 citations indexed

About

Xinyong Liu is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Xinyong Liu has authored 31 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 11 papers in Epidemiology and 10 papers in Hepatology. Recurrent topics in Xinyong Liu's work include Hepatitis C virus research (10 papers), Hepatitis B Virus Studies (9 papers) and HIV/AIDS drug development and treatment (9 papers). Xinyong Liu is often cited by papers focused on Hepatitis C virus research (10 papers), Hepatitis B Virus Studies (9 papers) and HIV/AIDS drug development and treatment (9 papers). Xinyong Liu collaborates with scholars based in China, United States and Taiwan. Xinyong Liu's co-authors include Peng Zhan, Zhenyu Li, Peng Zhan, Xiaohong Liang, Diwakar Rai, Chunhong Ma, Ji Hoon Yu, Xuemei Jiang, Ying C. Q. Zang and Wenjing Sun and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Sensors and Drug Discovery Today.

In The Last Decade

Xinyong Liu

29 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinyong Liu China 14 177 117 92 88 79 31 489
Louis Papageorgiou Greece 13 18 0.1× 40 0.3× 186 2.0× 79 0.9× 8 0.1× 50 429
Jiayu Wang China 14 12 0.1× 116 1.0× 133 1.4× 38 0.4× 25 0.3× 37 481
Sneha Gupta India 10 9 0.1× 174 1.5× 172 1.9× 121 1.4× 41 0.5× 35 507
Md Imam Faizan India 10 91 0.5× 48 0.4× 128 1.4× 94 1.1× 3 0.0× 23 375
Huajun Zhang China 10 6 0.0× 119 1.0× 145 1.6× 35 0.4× 37 0.5× 31 488
Gloria Figueroa Mexico 10 11 0.1× 41 0.4× 137 1.5× 26 0.3× 13 0.2× 22 403
Viviana Romero United States 11 7 0.0× 89 0.8× 91 1.0× 58 0.7× 62 0.8× 17 404
Jim Bush United Kingdom 14 19 0.1× 87 0.7× 138 1.5× 222 2.5× 5 0.1× 24 638
David Stein United States 10 13 0.1× 23 0.2× 223 2.4× 20 0.2× 13 0.2× 32 400
Onofrio Laselva Italy 22 18 0.1× 52 0.4× 276 3.0× 15 0.2× 25 0.3× 49 1.0k

Countries citing papers authored by Xinyong Liu

Since Specialization
Citations

This map shows the geographic impact of Xinyong Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinyong Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinyong Liu more than expected).

Fields of papers citing papers by Xinyong Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinyong Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinyong Liu. The network helps show where Xinyong Liu may publish in the future.

Co-authorship network of co-authors of Xinyong Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xinyong Liu. A scholar is included among the top collaborators of Xinyong Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinyong Liu. Xinyong Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Xinyong, et al.. (2025). Degradable plastics could help to protect the marine environment: proof based on pollutant surface behaviors. New Journal of Chemistry. 49(23). 9829–9837. 2 indexed citations
2.
Li, Xin, et al.. (2025). Recent advances of the respiratory syncytial virus inhibitors. Bioorganic & Medicinal Chemistry Letters. 129. 130365–130365.
3.
Wang, Zhao, Erik De Clercq, Christophe Pannecouque, et al.. (2024). Design and synthesis of Fsp3‐enriched spirocyclic‐substituted diarylpyrimidine derivatives as novel HIV‐1 NNRTIs. Chemical Biology & Drug Design. 103(3). e14510–e14510.
4.
Jiang, Xiangyi, et al.. (2024). Recent advances in the molecular design and applications of viral RNA-targeting antiviral modalities. Drug Discovery Today. 29(8). 104074–104074. 8 indexed citations
5.
Yang, Jianfeng, Xinyong Liu, Liangchao Chen, et al.. (2023). Analysis on causes of chemical industry accident from 2015 to 2020 in Chinese mainland: A complex network theory approach. Journal of Loss Prevention in the Process Industries. 83. 105061–105061. 32 indexed citations
6.
Xu, Shujing, Xufeng Wan, Yang Zhou, et al.. (2023). Medicinal chemistry strategies in the discovery and optimization of HBV core protein allosteric modulators (2018–2022 update). Chinese Chemical Letters. 34(11). 108349–108349. 11 indexed citations
7.
Zhang, Senlin, et al.. (2023). Longitudinal and Lateral Control Strategies for Automatic Lane Change to Avoid Collision in Vehicle High-Speed Driving. Sensors. 23(11). 5301–5301. 9 indexed citations
8.
Song, Xiaojia, Na Li, Yuan Liu, et al.. (2021). CD169-positive macrophages enhance abscopal effect of radiofrequency ablation therapy in liver cancer. Translational Oncology. 15(1). 101306–101306. 13 indexed citations
9.
Ma, Yue, Yujie Ren, Srinivasulu Cherukupalli, et al.. (2021). Design, synthesis and evaluation of heteroaryldihydropyrimidine analogues bearing spiro ring as hepatitis B virus capsid protein inhibitors. European Journal of Medicinal Chemistry. 225. 113780–113780. 16 indexed citations
10.
Liu, Xinyong, Wei Yu, Xiaoxi Fan, et al.. (2019). P1.14-10 The Landscape of RET Genomic Alterations in Chinese Non-Small Cell Lung Cancer Patients. Journal of Thoracic Oncology. 14(10). S556–S556. 1 indexed citations
11.
Yu, Ji Hoon, Xiaowei Guo, Shuo Zhang, et al.. (2019). Design, synthesis, and evaluation of novel heteroaryldihydropyrimidine derivatives as non‐nucleoside hepatitis B virus inhibitors by exploring the solvent‐exposed region. Chemical Biology & Drug Design. 95(6). 567–583. 13 indexed citations
12.
Mu, Di, Lingling Kong, Fanghui Zhao, et al.. (2017). CD8+/FOXP3+ Ratio and PD-L1 Expression Associated With Survival in pT3N0M0 Stage Esophageal Squamous Cell Cancer. International Journal of Radiation Oncology*Biology*Physics. 98(1). 228–228. 2 indexed citations
13.
Song, Yang, Ji Hoon Yu, Peng Zhan, et al.. (2017). Design, synthesis and primary biological evaluation of the novel 2-pyridone derivatives as potent non-nucleoside HBV inhibitors. European Journal of Medicinal Chemistry. 136. 144–153. 41 indexed citations
14.
Wang, Shuhua, Liying Guan, Dandan Luo, et al.. (2016). Gene- gene interaction between PPARG and APOE gene on late-onset Alzheimer's disease: A case- control study in Chinese han population. The journal of nutrition health & aging. 21(4). 397–403. 13 indexed citations
15.
Bai, Fuxiang, Na Liu, Xiaohong Liang, et al.. (2016). Design, synthesis and evaluation of pyrazole derivatives as non-nucleoside hepatitis B virus inhibitors. European Journal of Medicinal Chemistry. 123. 202–210. 31 indexed citations
16.
Liu, Na, Fabao Zhao, Peng Zhan, & Xinyong Liu. (2015). Review of Small Synthetic Molecules Targeting HBV Capsid Assembly. Medicinal Chemistry. 11(8). 710–716. 11 indexed citations
17.
Yang, Liya, et al.. (2014). Symptomatic unruptured isolated middle cerebral artery dissection: clinical and magnetic resonance imaging features. Clinical Neuroradiology. 26(1). 81–91. 18 indexed citations
18.
Zhan, Peng & Xinyong Liu. (2013). Rationally Designed Multitarget Anti-HIV Agents. Current Medicinal Chemistry. 20(13). 1743–1758. 25 indexed citations
19.
Li, X., Peng Zhan, Erik De Clercq, & Xinyong Liu. (2012). The HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (Part V ☆ ): Capravirine and Its Analogues. Current Medicinal Chemistry. 19(36). 6138–6149. 8 indexed citations
20.
Li, Zhenyu, Peng Zhan, & Xinyong Liu. (2011). 1,3,4-Oxadiazole: A Privileged Structure in Antiviral Agents. Mini-Reviews in Medicinal Chemistry. 11(13). 1130–1142. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Louis Papageorgiou Breakdown of academic impact, for papers by Jiayu Wang Breakdown of academic impact, for papers by Sneha Gupta Breakdown of academic impact, for papers by Md Imam Faizan Breakdown of academic impact, for papers by Huajun Zhang Breakdown of academic impact, for papers by Gloria Figueroa Breakdown of academic impact, for papers by Viviana Romero Breakdown of academic impact, for papers by Jim Bush Breakdown of academic impact, for papers by David Stein Breakdown of academic impact, for papers by Onofrio Laselva
Rankless by CCL
2026